Abstract
The inclusion and exclusion criteria used in clinical trials pose an obstacle to the
external validity of anticancer treatments in certain populations, requiring a different
approach to obtain this information. Prior to administering a drug to humans or a
new population, such as children, it is necessary to predict the exposure, efficacy,
and toxicity
... read more